While most women over age 50 schedule mammograms for breast cancer, only a minority who are also eligible for low-dose CT scans for lung cancer undergo those potentially lifesaving screenings. A new study shows that targeted outreach can close the gap.

The nuclear pore complex (NPC) controls what moves in and out of the cell nucleus. Scientists have long debated how its flexible components team up with transport factors to create a barrier that is both fast and highly selective. Using high-speed atomic force microscopy and synthetic nanopores, the researchers showed that transport factors continuously reorganize the NPCs central transporter to enhance its selectivity and speed. The findings overturn previous rigid or gel-like models of the nuclear pore complex, offering new insight into diseases—such as cancer and neurodegeneration—that are linked to NPC breakdown. They also provide a blueprint for designing smart, nanopore-based technologies for drug delivery and filtration.

BUFFALO, NY — December 3, 2025 — A new essay was published in Volume 17, Issue 11 of Aging-US on November 19, 2025, titled “On the intergenerational transfer of ideas in aging and cancer research: from the hypothalamus according to V.M. Dilman to the mTOR protein complex according to M.V. Blagosklonny.”

To better understand illnesses that originate in the body, including cancer as well as autoimmune and neurological disorders, West Virginia University biochemists are examining a molecular process that can initiate disease in the cells of humans and other mammals.

The Brain Tumour Research Centre of Excellence at the University of Plymouth is a hub for world-leading research into low-grade tumours including low-grade glioma, meningioma, and schwannoma. Renewed funding from the charity Brain Tumour Research will enable scientists to deepen their understanding of how these tumours develop and translate that knowledge into life-changing therapies.

Breast cancer is able to modify the lymphatic vessels through which it travels to the draining lymph nodes. From there, it can then spread to other parts of the body. A new finding by Finnish researchers may help develop targeted therapies that could prevent this spread.

Recently, a review article by the research teams led by Professor Chen Shiyi from Huashan Hospital, Professor Dai Li Hua from the Affiliated City Dong Hospital, and Director Wu Guanghui from the Affiliated Ningde Hospital was published in the renowned journal Research. The study emphasizes how robotic exoskeletons can significantly improve cancer patients' mobility, muscle strength, and gait training, while also contributing to psychological recovery through personalized support and real-time feedback. This innovation is poised to reshape the future of cancer rehabilitation.

Rice bioengineers have designed an erasable serum marker that could enable clinicians to detect problems or measure any changes in how a patient responds to treatment with greater precision, using simple, minimally-invasive testing.